Relevance of haemoglobin monitoring in apheresis plasma donors: A retrospective cohort study in Québec, Canada
Vox Sanguinis · 2023
DOI: 10.1111/vox.13523 ↗Kurz gefasst
Kohortenstudie in der Zeitschrift Vox Sanguinis, 2023. Verfasst von Antoine Lewin und 4 weiteren Autor:innen. Beteiligte Einrichtung: Medical Affairs and Innovation, Héma-Québec, Montréal, Québec, Canada. Hauptthemen laut MEDLINE: Hemoglobins, Blood Component Removal. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 11 Literaturangaben. Gefördert von: Héma-Québec.
Abstract (Originalsprache)
Background and Objectives Systematically measuring pre‐donation haemoglobin (Hb) levels might be overly cautious for apheresis plasma donation, since plasmapheresis entails a small loss of red blood cells. We explored the association between the frequency of apheresis plasma donation and capillary blood Hb levels. Materials and Methods This retrospective cohort study included donors who gave apheresis plasma at least twice between 24 October 2020 and 23 October 2022 in Québec, Canada. Results were stratified by sex and analysed with linear repeated‐measure mixed models with random intercepts.
Results
In total, 9535 men (mean age = 46.7 years) and 9409 women (mean age = 41.1 years) made ≥2, but no more than 16 apheresis plasma donations. Over an average of 9.2 months of observation, men maintained Hb levels well above the Hb deferral threshold, and their Hb levels decreased by only 0.17 g/dL between the 1st and 15th donation return ( p < 0.0001). Over an average of 9.0 months of observation, women also maintained adequate Hb levels, and their Hb levels decreased by 0.08 g/dL between the 1st and 15th donation return.
Conclusion
The frequency of apheresis plasma donation was not associated with clinically meaningful changes in Hb levels, neither in men nor in women. This evidence questions the relevance of systematically monitoring Hb for apheresis plasma donation, at least for donation frequencies of ≤7–8 times per year. However, an adverse impact of plasmapheresis on Hb levels cannot be ruled out for individuals donating more frequently or for longer than ~9 months.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Medical Affairs and Innovation, Héma-Québec, Montréal, Québec, Canada.
- Medical Affairs and Innovation, Héma-Québec, Québec, Québec, Canada.
- Transfusion Medicine, Héma-Québec, Montréal, Québec, Canada.
ORCID-Profile: Antoine Lewin
Förderung
- Héma-Québec
Zitieren
APA
Lewin, A., Germain, M., Renaud, C., Robitaille, N., & Latour, C. (2023). Relevance of haemoglobin monitoring in apheresis plasma donors: A retrospective cohort study in Québec, Canada. Vox Sanguinis. https://doi.org/10.1111/vox.13523
Vancouver
Lewin A, Germain M, Renaud C, Robitaille N, Latour C. Relevance of haemoglobin monitoring in apheresis plasma donors: A retrospective cohort study in Québec, Canada. Vox Sanguinis. 2023. doi:10.1111/vox.13523
BibTeX
@article{Lewin2023,
author = {Lewin, Antoine and Germain, Marc and Renaud, Christian and Robitaille, Nancy and Latour, Catherine},
title = {Relevance of haemoglobin monitoring in apheresis plasma donors: A retrospective cohort study in Québec, Canada},
journal = {Vox Sanguinis},
year = {2023},
doi = {10.1111/vox.13523}
}
EUVIMED